Annamaria Rapisarda

4.7k citations
38 papers · 3.8k indexed · 1 hit paper · h-index 26
Topics
Cancer, Hypoxia, and Metabolism (29 papers)Neuroblastoma Research and Treatments (7 papers)Cancer Research and Treatments (6 papers)
Partner nations
United StatesItalySpain

In The Last Decade

Annamaria Rapisarda

36 papers receiving 3.8k citations

Hit Papers

Regulation of the Chemokine Receptor CXCR4 by Hypoxia20032026201020182003200400600

Peers

Annamaria Rapisarda
Comparison fields: 5 of 117
  • Molecular Biology 2.0k
  • Cancer Research 1.9k
  • Oncology 1.1k
  • Immunology 881
  • Pulmonary and Respiratory Medicine 353
Replace Robert R. Langley with:
Robert R. Langley United States
You‐Hong Cui China
Rugang Zhang United States
Frédérique Végran France
Jordan S. Fridman United States
Tongsen Zheng China
Matvey Lukashev United States
Félix Bonilla Spain
Antonio Gualberto United States
Joyce E. Ohm United States
Annamaria Rapisarda relative to Robert R. Langley United States Robert R. Langley's profile →
Citations per field
00.5×1.5×2.1×
Robert R. Langley · 1×
Citations per year

Countries citing papers authored by Annamaria Rapisarda

Since Specialization
Citations

This map shows the geographic impact of Annamaria Rapisarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annamaria Rapisarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annamaria Rapisarda more than expected).

Fields of papers citing papers by Annamaria Rapisarda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annamaria Rapisarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annamaria Rapisarda. The network helps show where Annamaria Rapisarda may publish in the future.

Co-authorship network of co-authors of Annamaria Rapisarda

This figure shows the co-authorship network connecting the top 25 collaborators of Annamaria Rapisarda. A scholar is included among the top collaborators of Annamaria Rapisarda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annamaria Rapisarda. Annamaria Rapisarda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 315
2 0
3 23
4 63
5 1
6 152
7 100
8 95
9 20
10 109
11 136
12 211
13 45
14 16
15 47
16 81
17 36
18
Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
397
19 17
20 105

About Annamaria Rapisarda

Annamaria Rapisarda is a scholar working on Cancer Research, Biotechnology and Oncology, having authored 38 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (29 papers), Neuroblastoma Research and Treatments (7 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Cancer Research (1.9k citations), Immunology (881 citations) and Oncology (1.1k citations). Annamaria Rapisarda has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Giovanni Melillo, Badarch Uranchimeg, Robert H. Shoemaker, Subhra K. Biswas, Dominic A. Scudiero, Edward A. Sausville, Manuela Nebuloni, Alberto Mantovani, Sergio Bernasconi and Antonio Sica. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026